Search Results - christopher+witowski

2 Results Sort By:
MRSA Biofilm Inhibition
Competitive Advantages A novel antibiofilm agent Treats and prevents biofilm growth Inhibits drug resistant bacterial infections including MRSA Low toxicity towards mammalian cells Summary USF researchers have developed a method of treating or preventing drug resistant bacterial infections including methicillin-resistant biofilm infections...
Published: 11/7/2024   |   Inventor(s): Bill Baker, Lindsey Shaw, James McClintock, Charles Amsler, Jacqueline Fries, Christopher Witowski, Renee Fleeman
Keywords(s):  
Category(s): Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical
Treatment for the Neglected Tropical Disease Leishmaniasis
Competitive Advantages Potent activity against Leishmaniasis parasite Low toxicity to healthy cells Parasite shows no resistance Summary The marine sponge, Dendrilla membranosa, produces a series of compounds with varying degrees of biological activity against the parasite Leishmania donovani. USF researchers have developed novel...
Published: 11/7/2024   |   Inventor(s): Brian Vesely, Christopher Witowski, Dennis Kyle, John Maschek, Bill Baker
Keywords(s):  
Category(s): Technology Classifications > Medical > Infectious Diseases, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical